Organization (Academic)
New York Institute of Technology
ClinicalTrials.gov lists New York Institute of Technology as lead sponsor of 59 trials. It has 2 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 3 registered with a 2026 start date. The dashed outline is the pace from the 3 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 3.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo New York Institute of Technology, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers New York Institute of Technology: 59 lead-sponsored trials and 3 legal-entity registrations.
Disease areas (44)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Parkinson Disease | 14 |
| Pain | 6 |
| Autism Spectrum Disorder | 3 |
| Brain Concussion | 3 |
| Brain Injuries | 3 |
Showing 5 of 44 disease areas.
Trials by start year as sponsor or collaborator (17)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 3 |
| 2024 | 3 |
| 2023 | 6 |
| 2022 | 2 |
| 2021 | 8 |
| 2020 | 1 |
| 2019 | 2 |
| 2018 | 5 |
| 2017 | 3 |
Showing 10 of 17 years.
Prediction, not a registry value: median of 29 months from start to primary completion across 5 trials still running at the 2026-10-09 snapshot; 2 of 5 predicted trials reach the 36-month horizon; registered median of 12 months across 41 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Approved assets (2)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| Tyrosine | 2 |
| Nicotine Patch | 1 |
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 32% hit target (n=19) | 55% on time (n=22) |
Journals published in (150)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| The Journal of the American Osteopathic Association | 40 |
| Neurology | 4 |
| Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme | 3 |
| British journal of sports medicine | 3 |
| Journal of cachexia, sarcopenia and muscle | 3 |
Showing 5 of 150 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 60 | 2 | 2025-10-28 |
Organization relationships (5)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| State University of New York | Co sponsors trial with | 1 |
| Government of the United States of America | Co sponsors trial with | 1 |
| Michael J. Fox Foundation | Co sponsors trial with | 1 |
| American Osteopathic Association | Co sponsors trial with | 1 |
| Rutgers, The State University of New Jersey | Co sponsors trial with | 1 |
Latest dated events (121)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-03 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-02-02 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-02-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-10-28 | Patent granted | Granted US patents (PatentsView / USPTO) |
| 2025-10-15 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 121 events.
CLIA clinical laboratory certificates (1)
| Lab | Certificate | Status |
|---|---|---|
| NEW YORK INSTITUTE OF TECHNOLOGY | Certificate for PPM procedures | Active |
Biomarker capability evidence (8)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| DCD | Trial sponsor | Named in trial inclusion criteria |
| NF2 | Trial sponsor | Named in trial inclusion criteria |
| PAF1 | Trial sponsor | Named in trial inclusion criteria |
| GH1 | Trial sponsor | Named in trial exclusion criteria |
| DCD | Trial sponsor | Mentioned in trial text |
Showing 5 of 8 evidence rows.
Biomarkers this organization publishes on (31)
Shown in this order: most publications first.
Showing 5 of 31 biomarkers.
On Scientist.com
New York Institute of Technology is listed as a research supplier in the Scientist.com network.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, and workforce and board diversity, as filed.
Work with New York Institute of Technology College of Osteopathic Medicine - Physiology Core on Scientist.com
For prices, more details, or to contact New York Institute of Technology College of Osteopathic Medicine - Physiology Core, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.